14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GSK.L
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

GlaxoSmithKline plc stock upgraded from Hold/Accumulate to Buy Candidate after Thursday trading session.
(Updated on Apr 25, 2024)

Buy or Hold candidate since Apr 19, 2024 Gain 2.60% PDF

The GlaxoSmithKline plc stock price gained 0.275% on the last trading day (Thursday, 25th Apr 2024), rising from £1,636.00 to £1,640.50. During the last trading day the stock fluctuated 1.31% from a day low at £1,635.00 to a day high of £1,656.50. The price has risen in 5 of the last 10 days and is up by 0.71% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 7 million shares were bought and sold for approximately £11.05 billion.

The stock is moving within a horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect GlaxoSmithKline plc stock with a 90% probability to be traded between £1,601.48 and £1,731.35 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GSK.L Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 3.60%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The GlaxoSmithKline plc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at £1,654.39. On a fall, the stock will find some support from the short-term average at £1,619.93. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. The stock had a Golden Star Signal on Tuesday, December 19, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Tuesday, December 19, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for GlaxoSmithKline plc stock

GlaxoSmithKline plc finds support from accumulated volume at £1,611.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved £21.50 (1.31%) between high and low. For the last week, the stock has had daily average volatility of 1.60%.

Our recommended stop-loss: £1,560.77 (-4.86%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (GSK.L) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect GlaxoSmithKline plc to open at £1,644.00, and during the day (based on 14 day Average True Range), to move between £1,613.97 and £1,667.03, which gives a possible trading interval of +/-£26.53 (+/-1.62%) up or down from last closing price. If GlaxoSmithKline plc takes out the full calculated possible swing range there will be an estimated 3.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at £1,649.60 (0.55%) than the support at £1,611.20 (1.79%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

GlaxoSmithKline plc will release earnings BMO on Wednesday, May 01, 2024.The consensus among the analysts for the expected earnings (EPS) is $0.290. We will update the financials statements for GlaxoSmithKline plc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.14% in the first trading day after earnings release.

Is GlaxoSmithKline plc stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for GlaxoSmithKline plc stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 2.283 Buy Candidate Upgraded

Predicted Opening Price for GlaxoSmithKline plc of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
£1,644.00 ( 0.213%) £1,640.50

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GSK.L

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1,665.50 1.52 %
R2 1,657.29 1.02 %
R1 1,652.21 0.714 %
Current price: 1,640.50
Support S1 1,635.79 -0.287 %
S2 1,630.71 -0.597 %
S3 1,622.50 -1.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1,669.80 1.79 %
R2 1,660.00 1.19 %
R1 1,649.60 0.555 %
Current price 1,640.50
Support S1 1,611.20 -1.79%
S2 1,586.20 -3.31%
S3 1,568.00 -4.42%

GSK Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 22, 2024 Feb 22, 2024 Apr 11, 2024 £16.00 0.98%
2 Nov 16, 2023 Nov 16, 2023 Nov 16, 2023 £0 0%
3 May 18, 2023 May 18, 2023 May 18, 2023 £14.00 0.98%
4 Feb 01, 2023 Feb 23, 2023 Apr 13, 2023 £13.75 0.90%
5 Nov 02, 2022 Nov 17, 2022 Jan 12, 2023 £13.75 0.96%

FAQ

What is the symbol for GlaxoSmithKline plc Stock and on which exchange is it traded?
The symbol for GlaxoSmithKline plc is GSK.L and it is traded on the XLON (London Stock Exchange).

Should I buy or sell GlaxoSmithKline plc Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for GlaxoSmithKline plc stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy GlaxoSmithKline plc Stock?
GlaxoSmithKline plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy GlaxoSmithKline plc Stock.

What's the current price of GlaxoSmithKline plc Stock?
As of the end of day on the Apr 25, 2024, the price of an GlaxoSmithKline plc (GSK.L) share was £1,640.50.

What is the 52-week high and low for GlaxoSmithKline plc Stock?
The 52-week high for GlaxoSmithKline plc Stock is £1,725.81 and the 52-week low is £1,302.60.

What is the market capitalization of GlaxoSmithKline plc Stock?
As of the Apr 25, 2024, the market capitalization of GlaxoSmithKline plc is 66.576B.

When is the next earnings date for GlaxoSmithKline plc?
The upcoming earnings date for GlaxoSmithKline plc is May 01, 2024.
Click to get the best stock tips daily for free!

About GlaxoSmithKline plc

GlaxoSmithKline plc GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medic... GSK.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT